Posted on

cbd capsules press release

If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware.

Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.

What can I do to prevent this in the future?

Another way to prevent getting this page in the future is to use Privacy Pass. You may need to download version 2.0 now from the Chrome Web Store.

If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices.

Cloudflare Ray ID: 664f0041bc2c2de4 • Your IP : 193.188.21.42 • Performance & security by Cloudflare

The solution-focused formulations each provide 35mg of CBD, blended with clinically-studied ingredients at efficacious doses to target the most requested need-states associated with CBD: sleep, stress, and temporary inflammation. These products, available as liquid capsules, include:

The plnt brand offers a comprehensive assortment of full spectrum CBD hemp extract products, which contain the extensive range of cannabinoids, terpenes, bioflavonoids, flavonoids, and fatty acids naturally occurring in hemp. This includes less than 0.3% THC, and no synthetic ingredients, preservatives, artificial flavors, colors, or sweeteners.

Developed to meet the growing consumer demand for accessible, high quality CBD from trusted sources, these new and exclusive tincture and capsule formulas are produced with The Vitamin Shoppe’s promise of unrivaled quality, expertise, and value. Both brands are exclusively available at The Vitamin Shoppe and Super Supplements stores, as well as www.vitaminshoppe.com .

The plnt assortment includes standalone CBD in tincture potencies of 10mg, 20 mg, and 40 mg of CBD per serving, in vanilla and unflavored versions. Vegetarian liquid capsules are available in potencies of 10mg, 20mg, and 35mg of CBD per serving. Additional condition-specific formulas pair 20mg of CBD with efficacious doses of popular organic herbs and adaptogens, available as tinctures or liquid capsules, including:

Additionally, every Vthrive The Vitamin Shoppe product is made with clean ingredients, meaning no Magnesium Stearate, Stearic Acid, or Titanium Dioxide, as well as zero artificial colors, flavors or sweeteners.

Created from hemp grown on a family farm and harvested by hand in Vermont, plnt CBD is manufactured with a solvent-free extraction process that uses only water and plant-based oils. This environmentally friendly process guarantees greater purity and potency, yielding more naturally occurring hemp-based compounds.

Both the plnt and Vthrive The Vitamin Shoppe CBD product lines offer customers an easy-to-understand potency classification system with three tiers of strength, as well as solution-oriented blends that address specific need-states. Priced from $24.99 to $69.99, depending on CBD potency and added therapeutic ingredients, each product offers exceptional value in terms of CBD potency per serving in comparison to leading competitive brands. To shop the complete assortments, please visit www.vitaminshoppe.com/plntcbd and www.vitaminshoppe.com/vthrivecbd .

Maricann is a vertically integrated producer and distributor of cannabis for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) buildout and will continue to pursue new opportunities in Europe.

On September 12 th , 2018 Maricann shipped the first batch of Mariplant CBD capsules to be sold in Munich and the Greater Munich region followed by a shipment on September 14 th , 2018 to the Greater Cologne region.

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include references to the Company’s plan for a larger sale roll out of pharmacy distribution across Germany, the development of a full suite of products and expectations for additional orders. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

TORONTO, Sept. 14, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Maricann” or the “Company) is pleased to announce its first shipment of Mariplant CBD capsules to German pharmacies.

About Maricann Group Inc.

Burlington, Ontario, CANADA

The first shipment of capsules included Maricann’s differentiated CBD gel capsules that include the patent protected VESIsorb®. VESIsorb® is Maricann’s world class drug delivery technology that allows the Company to produce a superior product to the fast-growing European CBD market at a competitive price.